Evidence map›Paper›PMID 21355052›Full record

ArticleJournal of the American Society of Nephrology : JASN2011

Activation of PI3-kinase stimulates endocytosis of ROMK via Akt1/SGK1-dependent phosphorylation of WNK1.

Chih-Jen Cheng, Chou-Long Huang

Abstract read
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 68 citations in OpenAlex.

  1. Characterizing risk groups in papillary thyroid carcinoma through T-Cell mediated tumor cell killing-related genes: a pathway to therapeutic predictions.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. WNK pathways in cancer signaling networks.Cell communication and signaling : CCS · 2018
    Review
  11. Article
  12. Progesterone Receptor Regulation of Uterine Adaptation for Pregnancy.Trends in endocrinology and metabolism: TEM · 2018
    Review
  13. Article
  14. Article
  15. Article
  16. Emerging Targets of Diuretic Therapy.Clinical pharmacology and therapeutics · 2017
    Review
  17. Article
  18. Article
  19. Multistep regulation of autophagy by WNK1.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Chih-Jen ChengDepartment of Medicine, UT Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390-8856, USA.
Chou-Long Huang
National Defense Medical Center · TWThe University of Texas Southwestern Medical Center · US

Funding

UT Southwestern O'Brien Kidney Research Core CenterP30DK079328 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI MOE, ORSON W · 2007 to 2021
$16.9M
Membrane Trafficking of Renal Potassium ChannelR01DK059530 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI HUANG, CHOU-LONG · 2003 to 2014
$4.7M
NIDDK NIH HHS P30 DK079328NIDDK NIH HHS P30DK079328NIDDK NIH HHS R01 DK059530NIDDK NIH HHS R01DK-59530
6 · The paper itself

Abstract

WNK kinases stimulate endocytosis of ROMK channels to regulate renal K+ handling. Phosphatidylinositol 3-kinase (PI3K)-activating hormones, such as insulin and IGF 1, phosphorylate WNK1, but how this affects the regulation of ROMK abundance is unknown. Here, serum starvation of ROMK-transfected HEK cells led to an increase of ROMK current density; subsequent addition of insulin or IGF1 inhibited ROMK currents in a PI3K-dependent manner. Serum and insulin also increased phosphorylation of the downstream kinases Akt1 and SGK1 as well as WNK1. A biotinylation assay suggested that insulin and IGF1 inhibit ROMK by enhancing its endocytosis, a process that WNK1 may mediate. Knockdown of WNK1 with siRNA or expression of a phospho-deficient WNK1 mutant (T58A) both prevented insulin-induced inhibition of ROMK currents, suggesting that phosphorylation at Threonine-58 of WNK1 is important to mediate the inhibition of ROMK by PI3K-activating hormones or growth factors. In vitro and in vivo kinase assays supported the notion that Akt1 and SGK1 can phosphorylate WNK1 at this site, and we established that Akt1 and SGK1 synergistically inhibit ROMK through WNK1. We used dominant-negative intersectin and dynamin constructs to show that SGK1-mediated phosphorylation of WNK1 inhibits ROMK by promoting its endocytosis. Taken together, these results suggest that PI3K-activating hormones inhibit ROMK by enhancing its endocytosis via a mechanism that involves phosphorylation of WNK1 by Akt1 and SGK1.

Indexed as

EndocytosisGene Expression RegulationHEK293 CellsHumansImmediate-Early ProteinsInsulinInsulin-Like Growth Factor IIntracellular Signaling Peptides and ProteinsKidneyMinor Histocompatibility AntigensPatch-Clamp TechniquesPhosphatidylinositol 3-KinasesPhosphorylationPotassium Channels, Inwardly RectifyingProtein Serine-Threonine KinasesProto-Oncogene Proteins c-aktAKT1 protein, humanImmediate-Early ProteinsInsulinInsulin-Like Growth Factor IIntracellular Signaling Peptides and ProteinsKCNJ1 protein, humanMinor Histocompatibility AntigensPhosphatidylinositol 3-KinasesPotassium Channels, Inwardly RectifyingProtein Serine-Threonine KinasesProto-Oncogene Proteins c-aktRNA, Small InterferingSerum-Glucocorticoid Regulated KinasesWNK1 protein, humanWNK Lysine-Deficient Protein Kinase 1

Identifiers

PMID21355052
PMCPMC3060440
OpenAlexW2165874149

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.